<DOC>
	<DOC>NCT02265653</DOC>
	<brief_summary>The objective of the present study is to investigate the relative bioavailability of two BIIL 284 BS tablets (tablet C and tablet C) in comparison to the WIF tablet at a dose of 75 mg following a standard breakfast in healthy male volunteers</brief_summary>
	<brief_title>Relative Bioavailability, Pharmacokinetics, Safety and Tolerability of BIIL 284 BS in Healthy Volunteers</brief_title>
	<detailed_description />
	<criteria>All participants are healthy males Age range from 21 to 50 years BrocaIndex: within + 20% of their normal weight In accordance with Good Clinical Practice (GCP) and local legislation each volunteer is supposed to give their written informed consent prior to admission to the study Volunteers will be excluded from the study if the results of the medical examination or laboratory tests are judged by the clinical investigator to differ significantly from normal clinical values Volunteers with known gastrointestinal, hepatic, renal, respiratory, cardiovascular, metabolic, immunological or hormonal disorders Volunteers with diseases of the central nervous system (such as epilepsy) or with psychiatric disorders Volunteers with history of orthostatic hypotension, fainting spells or blackouts Volunteers with chronic or relevant acute infections Volunteers with history of allergy/hypersensitivity (including drug allergy) which is deemed relevant to the trial as judged by the investigator Volunteers who have taken a drug with a long halflife (&gt;= 24 hours) within one month or less than ten halflives of the respective drug before enrollment in the study Volunteers who received any drugs which might influence the results of the trial the week previous to the start of the study Volunteers who participated in another study with an investigational drug within the last two months preceding this study Volunteers who smoke (&gt; 10 cigarettes or 3 cigars or 3 pipes/day) Volunteers who drink more than 60g of alcohol per day Volunteers who are dependent on drugs Volunteers who participated in excessive physical activities (e.g. competitive sports) within the last week before the study Volunteers who have donated blood within the last 4 weeks (&gt;= 100 mL)</criteria>
	<gender>Male</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>October 2014</verification_date>
</DOC>